Secure Access to Critical Assets

Set permissions using role-based access controls to provision passwords to groups of users while protecting privileged accounts and assets.

Active Directory and Office 365 Integration

Active Directory and Office 365 Integration

  • Import users and user groups from Microsoft's Active Directory directly into Devolutions Password Server using the Server Console.
  • Synchronize accounts and groups automatically from your current Active Directory keeping your privileged accounts always up-to-date.
  • Bind specific permissions to Active Directory groups for automatic granting of access to users when they are added.

Active Directory and Office 365 Integration
Role-Based Access Control
Role-Based Access Control

Role-Based Access Control

  • Role-based access control allows for the creation of a granular protection system, which in turn provides admins with more flexibility.
  • Limit access to view, edit or manage privileged accounts. Restrictions are enforced based on predefined user roles.
  • Since permissions are granular when using a role-based access control, multiple permissions can be set on multiple entries all at once.
  • Security is inherited, preventing users from creating entries without providing them with appropriate sufficient security level.

Two-Factor Authentication

Two-Factor Authentication

  • Two-Factor Authentication adds an additional layer of protection, ensuring that only the right people have access to privileged accounts.
  • Devolutions Password Server provides multiple two-factor authentication options, including: Office 365, SMS, Email, Duo, Google Authenticator, Yubikey, Radius Server, VASCO, AuthAnvil, Azure Multi-Factor and SafeNet.
  • Two-Factor Authentication can be implemented system-wide or granularly at the user level.

Two-Factor Authentication

Request a Live Demo

Our team is dedicated to helping you get the most out of our solutions.

Schedule your live demo

Free Trial

Try Devolutions Password Server with complete features

FREE 30-DAY TRIAL